Company Overview
- Website
- mitrabiotech.com
- Phone
- (339) 999-2300
- Employees
- 27
- Founded in
- 2010
- Industry
- BioTech/Drugs
- NAICS Codes
-
32 - Manufacturing325 - Chemical Manufacturing3254 - Pharmaceutical and Medicine Manufacturing32541 - Pharmaceutical and Medicine Manufacturing54 - Professional, Scientific, and Technical Services541 - Professional, Scientific, and Technical Services
- SIC Codes
-
28 - Chemicals and Allied Products283 - Drugs
Financials & Stats
Revenue
$31B
Total Funding Amount
$27M
Recent News & Media
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
- Nov 2, 2024
- pmc.ncbi.nlm.nih.gov
Who rocked Mitra Biotech’s boat? Not Sequoia, Accel, not $85M in funding
- Nov 30, 2020
- the-ken.com
CANscript: clinically validated oncology drug efficacy platform
- Sep 1, 2020
- nature.com
Mitra Biotech Advances Development of Next-Generation Cancer Immunotherapies
- Oct 25, 2018
- biospace.com
This is how India can build its own Silicon Valley
- Oct 3, 2016
- weforum.org
Cancer-fighting start-up Mitra Biotech raises $27.4 million
- Aug 29, 2016
- thehindu.com
Who is Mitra Biotech
Mitra Biotech is a privately held biotechnology company headquartered in Woburn, Massachusetts. With a team of four employees, the company has generated revenue exceeding $10,000. Mitra Biotech specializes in advancing personalized cancer treatment through its phenotypic platforms. These platforms aim to predict an individual's response to various cancer treatments, enabling more tailored treatment selection and drug development. A key differentiator for Mitra Biotech is its CANscript™ platform. This unique technology offers individualized treatment response predictions, assisting in patient-specific cancer treatment decisions and enhancing drug discovery and development processes. Mitra Biotech can be contacted through their website, mitrabiotech.com.